CommentFor severe malaria, artesunate is the answer
References (10)
- et al.
Counterfeit anti-infective drugs
Lancet Infect Dis
(2006) - et al.
Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial
Lancet Infect Dis
(2010) - et al.
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial
Lancet
(2010) - et al.
A trial of artemether or quinine in children with cerebral malaria
N Engl J Med
(1996) - et al.
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial
Lancet
(2005)
There are more references available in the full text version of this article.
Cited by (6)
Artesunate to treat severe malaria in travellers: Review of efficacy and safety and practical implications
2017, Journal of Travel MedicineArtesunate induces apoptosis and inhibits growth of Eca109 and Ec9706 human esophageal cancer cell lines in vitro and in vivo
2015, Molecular Medicine ReportsDelayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with Artesunate, France, 2011–2013
2015, Emerging Infectious DiseasesTherapy of vector-borne protozoan infections in nonendemic settings
2011, Expert Review of Anti-Infective Therapy
Copyright © 2010 Elsevier Ltd. All rights reserved.